US venture Zentalis Pharmaceuticals, Inc. broke new ground when it raised around $190m in its successful Nasdaq IPO in early April after becoming the first company to hold an all-virtual roadshow and bell ringing ceremony on its trading debut.
It is now looking to break more ground outside the US with the establishment of a new joint venture in...




![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)

